Cargando…

Neuroprotective activity of a new erythropoietin formulation with increased penetration in the central nervous system

Detalles Bibliográficos
Autores principales:	Etcheverrigaray, Marina, Ceaglio, Natalia, Mattio, Mónica, Oggero, Marcos, Amadeo, Ignacio, Forno, Guillermina, Perotti, Norma, Kratje, Ricardo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2011
Materias:	Meeting Abstract
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3284997/ https://www.ncbi.nlm.nih.gov/pubmed/22373358 http://dx.doi.org/10.1186/1753-6561-5-S8-P3

Ejemplares similares

Differences in the production of hyperglycosylated IFN alpha in CHO and HEK 293 cells
por: Gugliotta, Agustina, et al.
Publicado: (2013)

New reporter cell clones to determine the biological activity of human type I interferons
por: Bürgi, Milagros, et al.
Publicado: (2011)

A strategy to obtain recombinant cell lines with high expression levels. Lentiviral vector-mediated transgenesis
por: Prieto, Claudio, et al.
Publicado: (2011)

Development of highly stable and de-immunized versions of recombinant alpha interferon: Promising candidates for the treatment of chronic and emerging viral diseases
por: Giorgetti, Sofía Inés, et al.
Publicado: (2021)

Erythropoietin use in the newborn
por: Buonocore, Giuseppe
Publicado: (2014)

Amphotericin B lipid formulations and target-site penetration into human body fluids
por: Weiler, Stefan, et al.
Publicado: (2008)

Erythropoietin: a multimodal neuroprotective agent
por: Byts, Nadiya, et al.
Publicado: (2009)

Neuroprotective effects of erythropoietin on neurodegenerative and ischemic brain diseases: the role of erythropoietin receptor
por: Hernández, Carolina Castillo, et al.
Publicado: (2017)

Neuroprotective Effects of Erythropoietin in Acute Ischemic Stroke
por: Asadi, Bahador, et al.
Publicado: (2013)

The Orphan Cytokine Receptor CRLF3 Emerged With the Origin of the Nervous System and Is a Neuroprotective Erythropoietin Receptor in Locusts
por: Hahn, Nina, et al.
Publicado: (2019)

Erythropoietin: New Directions for the Nervous System
por: Maiese, Kenneth, et al.
Publicado: (2012)

Alternative Erythropoietin Receptors in the Nervous System
por: Ostrowski, Daniela, et al.
Publicado: (2018)

Erythropoietin; a Novel Neuroprotective Agent for Ocular Disorders
por: Falavarjani, Khalil Ghasemi, et al.
Publicado: (2011)

Carbamylated Erythropoietin: A Prospective Drug Candidate for Neuroprotection
por: Chen, Jianmin, et al.
Publicado: (2016)

Neuroprotective effects of erythropoietin on rat retinas subjected to oligemia
por: de Carvalho, Litia Alves, et al.
Publicado: (2018)

Neuroprotective mechanisms of erythropoietin in a rat stroke model
por: Juenemann, Martin, et al.
Publicado: (2020)

The erythropoietin-derived peptide MK-X and erythropoietin have neuroprotective effects against ischemic brain damage
por: Yoo, Seung-Jun, et al.
Publicado: (2017)

Neuroprotective potential of erythropoietin in neonates; design of a randomized trial
por: Juul, Sandra E., et al.
Publicado: (2015)

Correction to: “Carbamylated Erythropoietin: A Prospective Drug Candidate for Neuroprotection”
por: Chen, Jianmin, et al.
Publicado: (2016)

Mitochondrial Metabolism as Target of the Neuroprotective Role of Erythropoietin in Parkinson’s Disease
por: Rey, Federica, et al.
Publicado: (2021)

Second-generation non-hematopoietic erythropoietin-derived peptide for neuroprotection
por: Cho, Bongki, et al.
Publicado: (2021)

Erythropoietin reduces experimental autoimmune encephalomyelitis severity via neuroprotective mechanisms
por: Moransard, M., et al.
Publicado: (2017)

Penetration Enhancement of Topical Formulations
por: Ng, Keng Wooi
Publicado: (2018)

Erythropoietin as a Neuroprotective Molecule: An Overview of Its Therapeutic Potential in Neurodegenerative Diseases
por: Rey, Federica, et al.
Publicado: (2019)

Prophylactic Erythropoietin for Neuroprotection in Very Preterm Infants: A Meta-Analysis Update
por: Fischer, Hendrik S., et al.
Publicado: (2021)

Erythropoietin administration exerted neuroprotective effects against cardiac ischemia/reperfusion injury
por: Chunchai, Titikorn, et al.
Publicado: (2022)

Prevention of infective complications of penetrating injuries to the head
por: Lei, LX, et al.
Publicado: (1999)

Voriconazole and target-site penetration into human tissue
por: Weiler, Stefan, et al.
Publicado: (2008)

Neurotherapeutic potential of erythropoietin after ischemic injury of the central nervous system
por: Simon, Florian, et al.
Publicado: (2019)

Hematologic safety of chronic brain-penetrating erythropoietin dosing in APP/PS1 mice
por: Sun, Jiahong, et al.
Publicado: (2019)

The Effects of a Blood–Brain Barrier Penetrating Erythropoietin in a Mouse Model of Tauopathy
por: Yang, Joshua, et al.
Publicado: (2023)

Neuroprotective Effect of Erythropoietin in Postoperation Cervical Spinal Cord Injury: Case Report and Review
por: Nekoui, Alireza, et al.
Publicado: (2015)

Neuroprotective effects of erythropoietin against oxidant injury following brain irradiation: an experimental study
por: Ugurluer, Gamze, et al.
Publicado: (2016)

Erythropoietin as a Neuroprotective Drug for Newborn Infants: Ten Years after the First Use
por: Perrone, Serafina, et al.
Publicado: (2022)

Evaluation of formulation properties and skin penetration in the same additive-containing formulation
por: Inoue, Yutaka, et al.
Publicado: (2014)

Penetration of polar organic compounds through the blood-brain barrier
por: Kalász, Huba, et al.
Publicado: (2011)

PW02-040 - Low-penetrance NLRP3 variants
por: Endres, T, et al.
Publicado: (2013)

Is there a role of hepatic enzymes in the management of penetrating hepatic injuries?
por: Pallett, JR, et al.
Publicado: (2013)

RF-Penetrable PET insert for simultaneous PET/MR imaging
por: Lee, Brian J, et al.
Publicado: (2014)

Diffusion Tensor Imaging Changes Do Not Affect Long-Term Neurodevelopment following Early Erythropoietin among Extremely Preterm Infants in the Preterm Erythropoietin Neuroprotection Trial
por: Law, Janessa B., et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_kggcldabua0ujjfi32hnkjoqhc